3H-Quinazolin-4-ones as a new calcilytic template for the potential treatment of osteoporosis.

Bioorg Med Chem Lett

Drug Discovery, NPS Pharmaceuticals, Inc., 383 Colorow Drive, Salt Lake City, UT 84108, USA.

Published: March 2005

Structure-activity relationship studies, focused on identification of the active pharmacophore fragments in a single high-throughput screening calcilytic hit, resulted in the discovery of potent calcium receptor antagonists, substituted 3H-quinazolin-4-ones.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2005.01.078DOI Listing

Publication Analysis

Top Keywords

3h-quinazolin-4-ones calcilytic
4
calcilytic template
4
template potential
4
potential treatment
4
treatment osteoporosis
4
osteoporosis structure-activity
4
structure-activity relationship
4
relationship studies
4
studies focused
4
focused identification
4

Similar Publications

3H-Quinazolin-4-ones as a new calcilytic template for the potential treatment of osteoporosis.

Bioorg Med Chem Lett

March 2005

Drug Discovery, NPS Pharmaceuticals, Inc., 383 Colorow Drive, Salt Lake City, UT 84108, USA.

Structure-activity relationship studies, focused on identification of the active pharmacophore fragments in a single high-throughput screening calcilytic hit, resulted in the discovery of potent calcium receptor antagonists, substituted 3H-quinazolin-4-ones.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!